Long-Term Management and What to Expect
At a Glance
Children with Majeed syndrome need lifelong, individualized follow-up even when they feel well. Targeted IL-1 medicines, whole-body MRI, blood tests, and growth and bone checks can help control inflammation and detect silent damage, while school and emotional support help with daily life.
While Majeed syndrome is a lifelong condition, the outlook for children today is significantly different than it was even a decade ago. In the past, the disease often led to permanent bone damage and severe growth issues [1][2]. Today, with the use of targeted IL-1 inhibitors, some reported patients have experienced substantial clinical improvement, allowing the body to heal and grow [3][4][5]. Remission is not a cure and long-term outcome data remain limited, but early treatment can help prevent long-term damage.
Long-Term Monitoring: Tracking the “Silent” Disease
Because Majeed syndrome is autoinflammatory, it can sometimes be “active” deep inside the bones even if your child isn’t complaining of pain [6]. For this reason, your medical team will use a monitoring schedule to stay ahead of the disease. There is no universal protocol; testing frequency depends on symptoms, laboratory trends, and the specific medications your child takes.
Whole-Body MRI (WB-MRI)
Periodic whole-body MRIs are often used for tracking Majeed syndrome [7]. These scans allow doctors to see the entire skeleton and detect “silent” bone lesions before they cause permanent damage or fractures [6][8]. However, MRI findings can sometimes lag behind clinical improvement, and scans may involve costs or require sedation. Imaging decisions are made alongside physical exams and symptoms.
Regular Blood Work
You can expect regular blood tests to monitor three key areas:
- Inflammatory Markers: Tracking ESR and CRP helps doctors see if the “fire” of the immune system is under control [9][5].
- Complete Blood Count (CBC): This is essential to monitor the anemia (red blood cells) and check for neutropenia (low white blood cells), which can be a feature of the disease or a side effect of medication [9][4].
- Organ Function: Regular checks of liver and kidney function ensure that long-term medications are being processed safely by the body [9][10].
Protecting Bone Health and Growth
If inflammation is left untreated or is poorly controlled, it can lead to several long-term physical complications:
- Growth Retardation: Chronic inflammation uses up the energy the body needs to grow, which can lead to failure to thrive or shorter stature [1][11].
- Bone Deformities: Repeated “flares” in the same bone can lead to thickening or bowing of the bone [12][13].
- Vertebral Fractures: The small bones of the spine (vertebrae) are particularly sensitive to inflammation. If they become weakened, they can develop “compression fractures,” which may cause height loss or a curved back [14][15].
Tracking growth on specialized charts and monitoring bone health are key parts of long-term care [4][11].
Navigating the Psychological Journey
Managing a rare chronic illness is a marathon, not a sprint. It is normal for both parents and children to experience “scan anxiety”—the stress that builds up before a major MRI or blood test [16].
- For the Child: Chronic pain and frequent medical visits can lead to social withdrawal or anxiety about missing school [17][16]. Connecting with a pediatric psychologist or a child life specialist early on can help your child develop healthy coping mechanisms for pain and medical procedures. Work with your care team to establish a 504 Plan or IEP (or your local equivalent) to ensure your child has accommodations for absences and physical limitations.
- For the Parent: The burden of coordinating care for a rare disease is significant. Seek out support groups for rare autoinflammatory diseases. Even if you don’t find another family with Majeed syndrome, the challenges of managing biologic injections and complex care teams are shared by many in the rare disease community [18][19].
With a dedicated care team and modern treatments, many children with Majeed syndrome can attend school, participate in activities, and live full, active lives [20][5]. Your role is to be their advocate and the bridge between their specialists.
Common questions in this guide
How is Majeed syndrome monitored over the long term?
Why might my child need a whole-body MRI when they do not have bone pain?
What blood tests are used to follow Majeed syndrome treatment?
Can treatment protect my child’s growth and bones?
What long-term problems can Majeed syndrome cause?
How can families support a child with Majeed syndrome at school and at home?
Get notified when new evidence is published on Majeed syndrome.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (20)
- 1
Majeed Syndrome: A Review of the Clinical, Genetic and Immunologic Features.
Ferguson PJ, El-Shanti H
Biomolecules 2021; (11(3)) doi:10.3390/biom11030367.
PMID: 33670882 - 2
Autoinflammatory Bone Diseases.
Haşlak F, Akay N, Gül Ü, et al.
Balkan medical journal 2025; (42(1)):5-13 doi:10.4274/balkanmedj.galenos.2024.2024-11-129.
PMID: 39757386 - 3
Novel Majeed Syndrome-Causing LPIN2 Mutations Link Bone Inflammation to Inflammatory M2 Macrophages and Accelerated Osteoclastogenesis.
Bhuyan F, de Jesus AA, Mitchell J, et al.
Arthritis & rheumatology (Hoboken, N.J.) 2021; (73(6)):1021-1032 doi:10.1002/art.41624.
PMID: 33314777 - 4
Majeed syndrome: first description in a patient of central-European ancestry.
Drago E, Bertoni A, Grossi A, et al.
Rheumatology (Oxford, England) 2025; (64(5)):3069-3073 doi:10.1093/rheumatology/keae480.
PMID: 39255247 - 5
Clinical and genetic analysis of Majeed syndrome caused by LPIN2 complex heterozygous mutation and literature review.
Wang S, Yu T, He X, et al.
Frontiers in pediatrics 2025; (13()):1602509 doi:10.3389/fped.2025.1602509.
PMID: 41113563 - 6
Bone metabolism and inflammatory characteristics in 14 cases of chronic nonbacterial osteomyelitis.
Ata Y, Inaba Y, Choe H, et al.
Pediatric rheumatology online journal 2017; (15(1)):56 doi:10.1186/s12969-017-0183-z.
PMID: 28693592 - 7
Chronic Non-Bacterial Osteomyelitis (CNO) in a Tertiary Center in Southern Italy: Response to Treatment and Outcome Stratification.
Loconte R, Donghia R, Francavilla M, et al.
Children (Basel, Switzerland) 2025; (12(4)) doi:10.3390/children12040451.
PMID: 40310110 - 8
Chronic Recurrent Multifocal Osteomyelitis Involving the Spine, Sternum, and Lower Extremities: A Case Report.
Huynh K, McLendon L, Woolnough L, Elder ME
Pediatrics 2024; (154(4)) doi:10.1542/peds.2024-067527.
PMID: 39323407 - 9
Compound heterozygous LPIN2 pathogenic variants in a patient with Majeed syndrome with recurrent fever and severe neutropenia: case report.
Liu J, Hu XY, Zhao ZP, et al.
BMC medical genetics 2019; (20(1)):182 doi:10.1186/s12881-019-0919-3.
PMID: 31727123 - 10
Anakinra-Induced Acute Liver Failure in an Adolescent Patient with Still's Disease.
Taylor SA, Vittorio JM, Martinez M, et al.
Pharmacotherapy 2016; (36(1)):e1-4 doi:10.1002/phar.1677.
PMID: 26749403 - 11
Whole-body MRI in the diagnosis of paediatric CNO/CRMO.
Andronikou S, Kraft JK, Offiah AC, et al.
Rheumatology (Oxford, England) 2020; (59(10)):2671-2680 doi:10.1093/rheumatology/keaa303.
PMID: 32648576 - 12
Chronic Recurrent Multifocal Osteomyelitis.
Rafferty BA, Thakrar P
The Medical clinics of North America 2024; (108(1)):227-239 doi:10.1016/j.mcna.2023.05.022.
PMID: 37951653 - 13
Comparing children and adults with chronic nonbacterial osteomyelitis.
Lenert A, Ferguson PJ
Current opinion in rheumatology 2020; (32(5)):421-426 doi:10.1097/BOR.0000000000000734.
PMID: 32744822 - 14
Neurosurgical management of vertebral lesions in pediatric chronic recurrent multifocal osteomyelitis: patient series.
Hug NF, Purger DA, Li D, et al.
Journal of neurosurgery. Case lessons 2023; (5(4)).
PMID: 36692064 - 15
Vertebral fractures and bone health in patients with chronic non-bacterial osteomyelitis at disease onset: insights from the monocentric CAMELOT cohort.
Chighizola CB, Di Taranto R, Amati A, et al.
Therapeutic advances in musculoskeletal disease 2025; (17()):1759720X251375183 doi:10.1177/1759720X251375183.
PMID: 41113089 - 16
Chronic recurrent multifocal osteomyelitis: a case report.
Açoğlu EA, Akçaboy M, Yıldız YT, et al.
Turk pediatri arsivi 2019; (54(4)):272-276 doi:10.14744/TurkPediatriArs.2018.69379.
PMID: 31949420 - 17
Chronic nonbacterial osteomyelitis (CNO) and chronic recurrent multifocal osteomyelitis (CRMO).
Zhao DY, McCann L, Hahn G, Hedrich CM
Journal of translational autoimmunity 2021; (4()):100095 doi:10.1016/j.jtauto.2021.100095.
PMID: 33870159 - 18
Chronic nonbacterial osteomyelitis: current perspectives in pediatric practice.
Başaran Ö, Yıldız AE, Bilginer Y, Özen S
The Turkish journal of pediatrics 2026; (68(1)):1-17 doi:10.24953/turkjpediatr.2026.7367.
PMID: 41871553 - 19
Chronic Nonbacterial Osteomyelitis: Insights into Pathogenesis, Assessment, and Treatment.
Nuruzzaman F, Zhao Y, Ferguson PJ
Rheumatic diseases clinics of North America 2021; (47(4)):691-705 doi:10.1016/j.rdc.2021.06.005.
PMID: 34635299 - 20
Patient-reported effectiveness and safety of Pamidronate in NSAIDs-refractory chronic recurrent multifocal osteomyelitis in children.
Juszczak B, Sułko J
Rheumatology international 2022; (42(4)):699-706 doi:10.1007/s00296-021-04886-4.
PMID: 34018012
This page explains long-term monitoring and support for children with Majeed syndrome for informational purposes only and does not constitute medical advice. Your child’s care team should guide decisions about treatment, testing, school support, and symptoms.